Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
ImmusanT, Inc.
3203
ImmusanT, Inc.
Technology
Biotechnology
Immusan T is a biotechnology company focused on developing a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease.
Suggest edits
Founded
2011
Raised
$20M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Biogen
Xconomy
HubSpot
Money Mover
Formlabs
Akamai
General Catalyst
Companies in the same industry
Daeki Tech
Attentive Therapeutics
Gossamer Bio
CER TEK BIO
Cedilla Therapeutics
ABAC Therapeutics (ABAC)
Lava Therapeutics
CELLINK
Catalog
Okogen
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Add round
11 Sep
2018
Undisclosed funding
JDRF T1D Fund
ImmusanT rakes in funding
PE HUB
13 Dec
2011
$20,000,000
Venture capital (Series A)
Vatera Healthcare Partners